AlphAIAlphAI — Financial news for AI agents
SEC EDGAR$PACS

Jergensen Joshua sold $1.7M of PACS

Jergensen Joshua (President & COO) sold 40,000 shares of PACS Group, Inc. (PACS) at an average of $43.13 ($43.08–$43.62, $1.73M total) across 2 trades on 2026-09-16 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Jergensen Joshua
Published Sep 17, 2026, 10:01 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 17, 2026, 10:07 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$PACS
Neutral
medium confidence
Mentioned
$PACS
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PACSNeutralLow
01

Why it matters

Insider sale of $1.7M may slightly affect short‑term sentiment but unlikely to drive price.

02

Market read

A modest insider sell; traders may monitor for any follow‑up activity.

03

What to watch

Potential upcoming corporate actions or personal liquidity needs not disclosed.

Relevance 5/10Novelty 4/10Timing: post‑market 2026‑09‑16 filing

Background

SEC Form 4 filing provides primary source disclosure of insider transactions.

Company-level read

Ticker impact

$PACSNeutralMedium confidence
Context

Form 4 disclosed President & COO sold $1.7M of shares via 10b5‑1 plan.

Expected impact

Potential slight downward pressure; unlikely to move price materially.

Evidence & confidence

Sale represents ~0.07% of total shares; typical for diversification, limited impact.

Market effects

Sector

Minimal effect on healthcare services sector; no broader trend indicated.

Regional

Limited to US markets where PACS trades.

Global

Low; isolated insider transaction.

Counterpoint

What could challenge this read

Sale could be routine diversification rather than a negative signal.

Key entities

  • Company
    PACS Group, Inc.

    Healthcare services provider listed on NYSE under ticker PACS.

  • Individual
    Jergensen Joshua

    President & COO of PACS, reporting the insider sale.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

PACS insider trading history →

Related articles

$PACSMedAI 8/10

What PACS Group (PACS) Said on Its Q3 Earnings Call

PACS Group reported 196 mature, 90 ramping, and 35 new skilled nursing facilities with occupancy ranging from 76.2% to 93.1%. The company acquired 32 Florida and 10 Texas skilled nursing operations post-quarter. PACS raised its 2026 revenue outlook to $5.95B-$6.05B and adjusted EBITDA to $685M-$695M, citing strength in existing operations and new acquisitions. Operating cash flow was $583.1M for the first nine months of 2026, with $707.4M in available liquidity.

finance.yahoo.com
$PACSHighAI 8/10

PACS Group Inc (PACS) (Q3 2026) Earnings Call Highlights: Revenue Tops

PACS Group Inc (NYSE:PACS) reported Q3 2026 revenue growth of 6.4%, with adjusted EBITDA up 33.6% to $175.7M. The company raised full-year guidance, citing strong occupancy and skilled mix improvements. PACS also highlighted a robust acquisition pipeline and integration plans for 31 Eduro facilities. Challenges include lower metrics at newly acquired facilities and ongoing government investigations.

finance.yahoo.com
$PACSHigh

Why is PACS stock surging today?

PACS Group Inc (PACS) stock rose 6.0% in after-hours trading after beating Q3 2026 earnings and revenue estimates. The company also raised its full-year 2026 Adjusted EBITDA and revenue guidance. Analysts maintain a 'Moderate Buy' rating with an average price target of $58.80. The surge was driven by company-specific news.

investing.com